Internal Tool · Confidential · May 2026
Competitor Analysis
Translate any budget into a head-to-head comparison, handle objections on the spot, or pull up a full battle card before your next meeting.
Campaign Budget
$
vs. Competitor
All EQ5 rates at $185 all-in CPM
🔍
Talk Track
Before You Compare — Ask the Competitor
Four questions that surface the true cost
Every competitor leads with a low headline CPM. These are the questions that turn a quoted rate into an apples-to-apples comparison. Send these to the client before the vendor selection conversation — what you'll see is that "cheaper" is rarely cheaper once the full scope is itemized.
Q1 · Channel & Placement Breakdown
What specific platforms and ad placements are included in the quoted CPM? Is the rate blended across multiple channel types? Provide a CPM and impression volume per channel.
Q2 · Premium Social Inclusion
Are Meta and LinkedIn included in the buy? If yes, at what CPM and what share of total impressions? Note: LinkedIn NPI-targeted HCP audiences cost $300–$1,000 CPM direct from the platform.
Q3 · PLD Delivery Method & Rate
Is prescriber-level data captured at the impression level or click level? What percentage of total served impressions are expected to be returned as identified NPI data?
Q4 · All-In Cost Confirmation
Do the quoted costs include audience data licensing, agency management fees, ad serving, and reporting? If not, provide an itemized all-in cost so a true comparison can be made.
EQ5 $185 all-in CPM (hub standard rate)
Incl. Bundled in EQ5 rate
Est. Industry estimate — competitor doesn't disclose
/ Capability available / not available
Cost Component Equals 5$185 all-in CMI Media~$140 all-in est. Swoop~$7–15 CPM quoted PulsePoint~$20–60 CPM quoted
Media Costs — What the CPM Buys
Meta (Facebook/Instagram) NPI Activation Premium HCP social — deterministic match against US NPI registry 90%+ Deterministic NPI match · included in CPM ~65%Probabilistic ✗ Not offeredProgrammatic display only ✗ Not offeredProgrammatic display only
LinkedIn NPI Activation Direct-platform rate for NPI custom audiences: $300–$1,000 CPM 50% Match rate · included in CPM ~ LimitedOften separate buy ✗ Not offered ✗ Not offered
Channel Breadth Activate the same NPI list across multiple platforms 20+ Meta, LinkedIn, TikTok, Pinterest, Reddit, X, Snap + more ~10Agency-orchestrated mix Programmatic display + audioSingle channel type Programmatic displaySingle channel type
Audience Data & Targeting
NPI-Matched Audience & Identity Resolution Cost to license + match an NPI list to the buy platform IncludedBundled in $185 $6K–$12K Est.Third-party data license $6K–$12K Est.Third-party data license $6K–$12K Est.Third-party data license
Agency & Service Fees — Often Undisclosed
Account Management Optimization, status calls, reporting cadence (per quarter) Included $12K–$20K Est. $6K–$12K Est. $6K–$12K Est.
User-Level Reporting (NPI/sFTP) Physician-level attribution delivery Included $6K–$10K Est. Not availableNo NPI-level reporting Segment-level onlyNo NPI-level reporting
Media Markup / Commission 15–20% standard on placed media through an agency N/ADirect buy 15–20% markupStandard agency commission N/ADirect platform N/ADirect platform
Ad Serving & Trafficking Included $1.5K–$3K Est. $1.5K–$3K Est. $1.5K–$3K Est.
PLD Passback Capability
Prescriber-Level Data Delivery Does the vendor return identified NPI data on served impressions? Included Probabilistic Not available Not available
% of Impressions PLD-Delivered Share of served impressions returned as identified NPI data 97% Impression-level identification — every served impression matched at delivery ~65% Probabilistic match estimate <5% Click-to-site ID only — avg CTR 0.1–0.3% <5% Click-to-site ID only — avg CTR 0.1–0.3%
PLD Methodology Every impression NPI-matched at delivery — no click required Probabilistic / hybrid identification HCP must click through to client site to be identified HCP must click through to client site to be identified
PLD Workaround Cost If vendor can't deliver PLD natively, third-party sourcing required N/A N/A $5K–$10K Est.Komodo/MMIT NPI match $5K–$10K Est.Komodo/MMIT NPI match
⚠ Competitor "all-in" estimates reflect what it actually costs to match EQ5 campaign capabilities once data, agency fees, reporting, and PLD workarounds are itemized. EQ5 is a single invoice with no hidden fees. CMI requires 3–6 line items coordinated through the agency with undisclosed management fees layered on top. Swoop and PulsePoint cannot match EQ5's NPI social activation at any price — programmatic display alone is a different product category.
Effective All-In CPM After data, fees, reporting, PLD workaround $185 Truly all-in · one invoice ~$140 $65 quoted PLD + media + fees ~$25–45 Display-only · no premium social · no native PLD ~$45–80 Display-only · no premium social · no native PLD
Why Equals 5 Delivers More Value
Beyond the headline CPM
One invoice, no add-ons
$185 covers media, NPI audience data, account management, sFTP/CRM delivery, ad serving, and physician-level reporting. Competitors quote media-only and add the rest as line items.
97% PLD delivery vs <5% click-based
Every impression is NPI-matched at delivery — not just the ones that click. Click-based PLD returns identified data on the small fraction of HCPs who interact. The data feed difference is 20×, not marginal.
CPM reality check
LinkedIn NPI custom audiences cost $300–$1,000 CPM direct. Quoted vendor CPMs under $50 cannot include meaningful premium social inventory. The math doesn't work without channel-mix transparency.

Key Assumptions & Source Notes

  • EQ5 $185 all-in CPM is the hub standard rate covering Meta + LinkedIn NPI activation, audience data, account management, sFTP/CRM delivery, ad serving, and physician-level reporting. Specific account rates may vary based on contract — see the Rates section for current pricing.
  • CMI all-in $140 derived from CMI's frequently-quoted $65 PLD CPM plus estimated media buy ($45–$55), agency markup (15–20%), and account management fees ($3K–$5K/month) bundled across a typical campaign.
  • Audience data licensing ($6K–$12K) is the standard cost to procure an NPI-matched audience list from a third-party data provider. EQ5 bundles this; most competitors require it as a separate line item.
  • Agency fees ($6K–$20K) reflect typical pharma agency retainers for managing a multi-vendor digital campaign at $3K–$5K/month. This is the cost CMI does not disclose in their vendor comparisons.
  • Media markup assumes 15–20% commission on media placed through agency-led buys — standard practice when an agency intermediates the buy.
  • PLD workaround cost ($3K–$10K) covers sourcing prescriber-level data through Komodo, MMIT, or equivalent when the vendor cannot deliver PLD natively. Required for Swoop, PulsePoint, PatientPoint, and partially for Doceree.
  • Competitor CPMs under $50 are inconsistent with premium social inventory. LinkedIn custom audience (NPI-matched HCP) targeting costs $300–$1,000 CPM when purchased directly. The quoted competitor rates ($20–$60) are programmatic display, not premium social — confirm channel mix before drawing comparisons.
  • 97% PLD delivery rate is EQ5's standard production figure — every served social impression is NPI-matched at delivery via the deterministic match infrastructure. The 3% gap reflects rare match failures and platform-level reporting delays.
  • 90%+ NPI match rate is EQ5's standard rate across the US prescriber population — deterministic, not modeled. Meta specifically achieves 90%+ via NPI-linked identity matching against US NPI registry. Updated proof point per May 2026 figures.
CMI Media
HCP Digital Media · NPI Targeting · Direct Competitor
The most frequently cited head-to-head competitor — typically positioned on CPM. They quote $65 for PLD only; true all-in is ~$140.
We Win Most
  • 20+ social channels vs CMI's ~10 — more reach from the same NPI list
  • Deterministic NPI matching on Meta (85% match rate vs CMI's probabilistic model)
  • LinkedIn activation included — CMI's LinkedIn is limited or separate
  • All-in pricing transparency — $185 covers dashboard, sFTP, FIA, CRM, reporting
  • EQ5 + RMN Uni 5™ for rare disease — CMI has no equivalent specialty content play
  • IQM monthly optimization loop — CMI delivers static campaigns
  • CMI's $65 quoted CPM sounds much cheaper — reframe to all-in comparison
  • Long-standing agency relationships at Publicis, VMLY&R, Syneos
  • CMI has more brand recognition with junior agency buyers
  • May offer volume discounts on large deals that close the $45 gap further
CPM Objection Talk Track
"I hear that — CMI's $65 sounds significantly cheaper. But that's their PLD component only. Their all-in Meta CPM is approximately $140 once you add media and account management. Our $185 all-in covers NPI audience data, cross-channel activation across 20+ platforms, campaign dashboard access, sFTP data delivery, CRM integration, custom FIA coordination, and physician-level reporting. The real gap is $45 — not $120. And that $45 gets you deterministic matching at 85% on Meta versus CMI's probabilistic model, plus LinkedIn, TikTok, and 17 other channels from a single target list."
Rare Disease Differentiator Talk Track
"For rare disease specifically, there's no comparison. EQ5 + RMN is the only integrated solution that combines 100% deterministic NPI social targeting with a rare disease-specific content environment. CMI can activate social — but they can't drive those HCPs to specialty rare disease content and measure engagement back at the NPI level. Our Uni 5™ solution is purpose-built for exactly this use case."
DeepIntent
Healthcare DSP · AI-Powered Programmatic · Indirect Competitor
AI-powered programmatic platform focused on outcomes-based HCP targeting. Strong in programmatic display; limited social activation compared to EQ5.
We Win on Social
  • Social-first activation — DeepIntent is primarily programmatic display
  • Meta and LinkedIn at NPI level — DeepIntent's social integration is limited
  • 20+ channels from one NPI list — DeepIntent requires separate buy structures
  • Transparent all-in CPM pricing — DeepIntent is known for complex, layered fees
  • EQ5 + RMN rare disease content integration — DeepIntent has no equivalent
  • Faster onboarding and campaign launch — typically 1–2 weeks vs 4+ weeks
  • Strong AI/ML narrative — "outcomes-based" resonates with quantitative buyers
  • Better programmatic scale than EQ5 — large reach at lower CPMs
  • Growing EHR partnerships (Veeva, Epic adjacent) — broad data signals
  • Well-funded with strong brand presence at pharma marketing conferences
Social vs. Programmatic Talk Track
"DeepIntent is excellent at programmatic display — but display is one channel. We activate the same NPI list across Meta, LinkedIn, TikTok, Pinterest, Reddit, and 15+ additional social channels simultaneously. HCPs are on social an average of 3+ hours per day outside of EHR and clinical portals. That's where we reach them with your message — in their actual environment, not just in display windows they tune out."
Complementary Positioning (if they already use DeepIntent)
"You're getting great programmatic coverage with DeepIntent. We complement that — not compete with it. They own display. We own social. Your target list runs across both environments, and you get NPI-level data from both streams. It's the full omnichannel picture that DeepIntent alone can't give you."
Doceree
HCP Point-of-Care & Social · Global Platform
Global HCP marketing platform. Strongest in non-US markets; US social activation is developing and match rates are significantly lower than EQ5.
Clear EQ5 Advantage
  • US NPI database depth — Doceree's US match rates are significantly lower
  • Meta match rate 85% (EQ5) vs Doceree's estimated 40–50% US match
  • Transparent physician-level reporting — Doceree typically reports at aggregate
  • US pharma compliance infrastructure — Doceree's MLR process less established
  • 20+ channel activation breadth — Doceree focuses on fewer platforms
  • EQ5 Identi-5™ attribution vs Doceree's point-of-care engagement proxy
  • Lower CPM positioning — may appear significantly cheaper in initial quotes
  • Global pharma relationships (J&J, Pfizer international) may have US carry-over
  • Growing point-of-care (POC) + social bundle pitch
US Match Rate Talk Track
"Doceree is a strong platform globally — but US HCP matching is where the difference becomes significant. Our Meta match rate is 85% deterministic against US NPI registries. Their US social match rates are estimated 40–50%, which means nearly half your budget is reaching non-HCPs or incorrectly matched records. For a $200K campaign, that's $80–100K hitting the wrong audience. Our NPI data infrastructure is built specifically around US prescriber data."
PulsePoint
Healthcare Programmatic DSP · Content Targeting
Programmatic display with healthcare content targeting. No social activation or NPI-level matching — fundamentally different product category from EQ5.
Different Category
  • NPI-level targeting — PulsePoint uses contextual/behavioral, not NPI deterministic
  • Social activation (Meta, LinkedIn) — PulsePoint is display-only
  • Physician-level attribution — PulsePoint reports at audience segment level
  • Campaign optimization via IQM — PulsePoint has no equivalent feedback loop
  • Rare disease content integration via RMN — PulsePoint has no specialty play
  • Lower CPMs ($20–60 range) — sounds dramatically cheaper at first glance
  • Scale — PulsePoint reaches broader audiences through publisher networks
  • Common in programmatic-first media plans — may be entrenched
Apples-to-Oranges Talk Track
"PulsePoint and Equals 5 aren't really comparable — they're different products. PulsePoint does contextual programmatic display: they target based on content environment and behavioral signals. We target actual physicians by their NPI number on social media. Think of it this way: PulsePoint tries to be where doctors might be reading. We know exactly which doctors you want to reach and we find them on the platforms they use personally. You probably want both — contextual in clinical environments and NPI-precise social outside of them."
PatientPoint
Point-of-Care Network · Waiting Room & EHR Advertising
Point-of-care advertising in clinical settings via digital screens and EHR integrations. No social activation or NPI social targeting.
Complementary, Not Competing
  • Social / outside-the-office reach — PatientPoint is in-office only
  • NPI-level social attribution — PatientPoint attribution is impression-based
  • Prescription influence at the prescriber's personal channels — not just clinical
  • 20+ activation channels from one audience list — PatientPoint is one environment
  • Rare disease specialty audience quality via RMN — PatientPoint is broad
  • Strong in primary care and large health systems — entrenched in those budgets
  • Different budget bucket (point-of-care vs. digital media) — may not be competing dollars
  • Patient and HCP reach in one network — can seem like a "two for one" buy
Complement Positioning Talk Track
"PatientPoint is a great in-office buy — but the physician's decision-making doesn't stop when they leave the exam room. We reach the same HCPs on their personal devices, on social media, after hours, where they consume clinical literature and peer updates. The most effective pharma programs combine point-of-care for in-office reinforcement with social for outside-the-office influence. PatientPoint and EQ5 are typically bought from different budget lines — it doesn't have to be either/or."
IQVIA Digital
Healthcare Data & Measurement Giant · Programmatic + DTC · Indirect Competitor
The industry's data and Rx-measurement backbone (OneKey reference data + claims). Powerful in programmatic display, CTV, and claims-based DTC — but no native NPI-level social activation.
We Win on Social
  • Native NPI-level social — IQVIA activates programmatic/CTV/DTC, not deterministic Meta, LinkedIn, and TikTok at the prescriber level
  • Impression-level deterministic NPI match (97% PLD) vs IQVIA's programmatic, audience-matched delivery
  • NPI-level reporting from social walled gardens — IQVIA reports social at modeled/aggregate level
  • 20+ social channels from one NPI list — IQVIA's strength is display, video, and CTV, not social
  • Transparent all-in CPM and fast launch vs enterprise SOW complexity and lead times
  • EQ5 + RMN rare disease content integration — IQVIA has no equivalent specialty social play
  • Unmatched data assets — OneKey + claims underpin the entire industry's measurement
  • Gold-standard Rx / script-lift attribution — very hard to beat on outcomes proof
  • Deep, incumbent enterprise relationships and trust at every major pharma
  • Can bundle data, audience, media, and measurement into a single enterprise deal
  • "Single source of truth" narrative resonates with analytics and insights buyers
Channel vs. Data Talk Track
"IQVIA owns the data and measurement layer — no one disputes that. But owning the data isn't the same as owning the channel. They deliver through programmatic display, CTV, and claims-based DTC. We activate the same prescribers natively on Meta, LinkedIn, TikTok, and 17+ other social channels — and return 97% of impressions as identified NPI data. Use us for the social layer their stack can't reach, then feed that prescriber-level data right back into the IQVIA measurement you already trust."
Complementary Positioning (if they already use IQVIA)
"If you're already running IQVIA for measurement, we make that investment work harder. We're the NPI-level social activation layer — the 'blue jeans' channel where physicians spend 10–15x more time than any clinical or endemic environment. Our data feeds your existing closed-loop Rx measurement. You don't replace IQVIA; you give it a social signal it doesn't have today."
Apples-to-Apples
The gap is the capabilities — not the cost.
Every competitor quotes a low headline CPM. The table below shows what you actually get — and what you don’t — when you compare NPI methodology, attribution depth, reporting, and fees line by line.
Capability Equals 5 IQVIA Digital PulsePoint Swoop CMI
Social & NPI Targeting
Social HCP ActivationMeta & LinkedIn NPI-targeted ✓ Meta & LinkedIn
NPI Targeting MethodHow each HCP is identified & matched 100% deterministic Modeled Modeled Modeled Modeled
NPI List Match Rate% of submitted NPI list confirmed matched 90%+ Unknown Unknown Unknown Unknown
NPI Attribution
NPI Impression AttributionNPI identified at the impression level — no click required 97% Unavailable Unavailable Unavailable Unavailable
NPI Click AttributionNPI identified on HCP click-through 97% Low · onsite pixel only Low · onsite pixel only Low · onsite pixel only Low · onsite pixel only
Reporting & CRM
NPI Unique Reach ReportingIndividual physician-level reach data ✓ Yes Aggregate Aggregate Aggregate Aggregate
Physician-Level ReportsGranularity of delivered reporting Full NPI detail Aggregate Limited Aggregate Aggregate
CRM IntegrationSalesforce, Veeva, sFTP passback Included Separate Fee Separate Fee Separate Fee Separate Fee
Cost Structure
Monthly Admin / Agency FeesOngoing management & coordination fees None · Included $10K–$25K/mo $10K–$25K/mo $10K–$25K/mo $10K–$25K/mo
All-in CPM*True all-in after data, fees & reporting $185Truly all-in · one invoice ~$120+ ~$100+ ~$95+ ~$65 PLD only
~$140 all-in
* CPM note: CMI's $65 CPM = PLD component only. All-in (media + data + reporting) = ~$140. EQ5's $185 includes all six components above: social activation, NPI impression attribution, physician-level reporting, NPI unique reach, CRM integration, and account management. No add-ons, no monthly fees.
📊
The Bottom Line for Brand Teams
Every competitor activates social. Only EQ5 identifies who saw it.
At 97% NPI impression attribution, every served impression comes back as an identified physician — not a click-dependent trickle. That data feeds CRM, Veeva, rep triggers, and closed-loop Rx measurement at a volume the others simply cannot match. The capability gap is what justifies the CPM gap.